Your research cart is empty.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
High-purity, structurally verified peptide sequences for advanced laboratory and pre-clinical applications.
Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue. With the molecular formula C₃₈H₄₉N₉O₅ and a molecular weight of 711.9 g/mol (CAS: 170851-70-4), Ipamorelin is derived...
Lab Verified
Clinical Grade
PMID Cited
Published preclinical research has characterized the following molecular pathways and receptor interactions for Ipamorelin.
Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) on somatotrophs, stimulating growth hormone release without significantly affecting other pituitary hormones (PMID: 10698741).
Receptor activation triggers phospholipase C-mediated signaling, increasing intracellular calcium and activating protein kinase C (PMID: 11916262).
Raun et al. (1998) characterized Ipamorelin's selective binding to GHS-R1a receptors and its effects on growth hormone release in pituitary cell cultures (PMID: 10698741).
Johansen et al. (2002) investigated Ipamorelin's receptor binding kinetics and signaling pathways in CHO cells expressing GHS-R1a (PMID: 11916262).
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
GH SecretagoguesC152H252N44O42 · 3367.9 g/mol
For in vitro research use only. Not for human consumption.
GH SecretagoguesBlend · Mixed
For in vitro research use only. Not for human consumption.
GH SecretagoguesC228H388N86O64 · 5358.06 g/mol
For in vitro research use only. Not for human consumption.